CP-690,550 Pharmacokinetics In Healthy Chinese Subjects

NCT01101919 ↗

Phase 1 Completed 12 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is designed to evaluate the levels of CP-690,550 in the blood of healthy Chinese subjects following both single doses and multiple doses of drug.

Timeline

Start: 2010-10
Primary completion: 2010-10
Completion: 2010-10

Publications

Krishnaswami S, Wang T, Yuan Y, Alvey CW, Checchio T, Peterson M, Shi H, Riese R. Single- and multiple-dose pharmacokinetics of tofacitinib in healthy Chinese volunteers. Clin Pharmacol Drug Dev. 2015 Sep;4(5):395-9. doi: 10.1002/cpdd.202. Epub 2015 Jul 16.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Tofacitinib	Small molecule	10 mg	Oral

Indications

No indication recorded.